Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 35573-428

2 FDA label images from Burel Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 35573-428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Burel Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (40 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (40 mg Blister Carton (10 x 10 Unit-dose))
Packaging label for Pantoprazole Sodium Delayed-Release Tablets, USP 40 mg by Burel Pharmaceuticals, LLC. The carton indicates 100 (10 x 10) unit-dose tablets, with instructions for pharmacists to dispense the medication guide separately. The label includes storage information and manufacturer details, including Aurobindo Pharma Limited in India.*
FDA Label Image

Chemical Structure (Pantoprazole Str)

Chemical Structure (Pantoprazole Str)
Chemical structure of pantoprazole sodium, including its sodium ion and water of hydration components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.